nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—DRD2—attention deficit hyperactivity disorder	0.437	0.564	CbGaD
Cisapride—HTR2A—attention deficit hyperactivity disorder	0.338	0.436	CbGaD
Cisapride—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00544	0.13	CbGeAlD
Cisapride—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00289	0.0692	CbGeAlD
Cisapride—HTR4—brain—attention deficit hyperactivity disorder	0.00257	0.0615	CbGeAlD
Cisapride—Iloperidone—ADRA2C—attention deficit hyperactivity disorder	0.0023	0.235	CrCbGaD
Cisapride—HTR3A—forebrain—attention deficit hyperactivity disorder	0.00167	0.04	CbGeAlD
Cisapride—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00134	0.0322	CbGeAlD
Cisapride—HTR2B—forebrain—attention deficit hyperactivity disorder	0.00126	0.0302	CbGeAlD
Cisapride—Iloperidone—DRD4—attention deficit hyperactivity disorder	0.00125	0.128	CrCbGaD
Cisapride—Iloperidone—DRD3—attention deficit hyperactivity disorder	0.00108	0.11	CrCbGaD
Cisapride—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.00107	0.0256	CbGeAlD
Cisapride—Metoclopramide—DRD3—attention deficit hyperactivity disorder	0.00107	0.109	CrCbGaD
Cisapride—Iloperidone—DRD1—attention deficit hyperactivity disorder	0.00106	0.108	CrCbGaD
Cisapride—DRD2—forebrain—attention deficit hyperactivity disorder	0.00102	0.0245	CbGeAlD
Cisapride—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00101	0.0241	CbGeAlD
Cisapride—Iloperidone—ADRA2A—attention deficit hyperactivity disorder	0.000981	0.1	CrCbGaD
Cisapride—HTR3A—nervous system—attention deficit hyperactivity disorder	0.000907	0.0217	CbGeAlD
Cisapride—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000887	0.0212	CbGeAlD
Cisapride—HTR3A—central nervous system—attention deficit hyperactivity disorder	0.000873	0.0209	CbGeAlD
Cisapride—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000851	0.0204	CbGeAlD
Cisapride—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.000838	0.0201	CbGeAlD
Cisapride—Iloperidone—DRD2—attention deficit hyperactivity disorder	0.000744	0.0761	CrCbGaD
Cisapride—Metoclopramide—DRD2—attention deficit hyperactivity disorder	0.000738	0.0754	CrCbGaD
Cisapride—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000729	0.0175	CbGeAlD
Cisapride—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000702	0.0168	CbGeAlD
Cisapride—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000699	0.0167	CbGeAlD
Cisapride—HTR3A—brain—attention deficit hyperactivity disorder	0.000693	0.0166	CbGeAlD
Cisapride—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000692	0.0166	CbGeAlD
Cisapride—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000685	0.0164	CbGeAlD
Cisapride—CYP2A6—brain—attention deficit hyperactivity disorder	0.000681	0.0163	CbGeAlD
Cisapride—DRD2—midbrain—attention deficit hyperactivity disorder	0.000675	0.0162	CbGeAlD
Cisapride—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000674	0.0161	CbGeAlD
Cisapride—KCNH2—midbrain—attention deficit hyperactivity disorder	0.000665	0.0159	CbGeAlD
Cisapride—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.00066	0.0158	CbGeAlD
Cisapride—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000614	0.0147	CbGeAlD
Cisapride—Iloperidone—HTR2A—attention deficit hyperactivity disorder	0.000575	0.0588	CrCbGaD
Cisapride—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.00057	0.0136	CbGeAlD
Cisapride—HTR2C—brain—attention deficit hyperactivity disorder	0.000557	0.0133	CbGeAlD
Cisapride—DRD2—nervous system—attention deficit hyperactivity disorder	0.000555	0.0133	CbGeAlD
Cisapride—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000547	0.0131	CbGeAlD
Cisapride—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000534	0.0128	CbGeAlD
Cisapride—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.000526	0.0126	CbGeAlD
Cisapride—HTR2B—brain—attention deficit hyperactivity disorder	0.000524	0.0125	CbGeAlD
Cisapride—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000522	0.0125	CbGeAlD
Cisapride—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.000514	0.0123	CbGeAlD
Cisapride—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000449	0.0107	CbGeAlD
Cisapride—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000445	0.0107	CbGeAlD
Cisapride—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000432	0.0103	CbGeAlD
Cisapride—DRD2—brain—attention deficit hyperactivity disorder	0.000424	0.0102	CbGeAlD
Cisapride—KCNH2—brain—attention deficit hyperactivity disorder	0.000418	0.01	CbGeAlD
Cisapride—CYP2C8—brain—attention deficit hyperactivity disorder	0.000382	0.00915	CbGeAlD
Cisapride—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000366	0.00876	CbGeAlD
Cisapride—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000352	0.00843	CbGeAlD
Cisapride—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000344	0.00824	CbGeAlD
Cisapride—CYP2B6—brain—attention deficit hyperactivity disorder	0.000343	0.00821	CbGeAlD
Cisapride—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000339	0.00811	CbGeAlD
Cisapride—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000333	0.00798	CbGeAlD
Cisapride—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000326	0.00781	CbGeAlD
Cisapride—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000321	0.00768	CbGeAlD
Cisapride—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000314	0.00751	CbGeAlD
Cisapride—HTR2A—brain—attention deficit hyperactivity disorder	0.00028	0.0067	CbGeAlD
Cisapride—CYP2D6—brain—attention deficit hyperactivity disorder	0.000255	0.0061	CbGeAlD
Cisapride—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.5e-05	0.000374	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.4e-05	0.000368	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.39e-05	0.000367	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.38e-05	0.000367	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.31e-05	0.000363	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.31e-05	0.000363	CbGpPWpGaD
Cisapride—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.29e-05	0.000362	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.29e-05	0.000361	CbGpPWpGaD
Cisapride—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.25e-05	0.000359	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.24e-05	0.000359	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.24e-05	0.000358	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.23e-05	0.000358	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.21e-05	0.000357	CbGpPWpGaD
Cisapride—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.21e-05	0.000357	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.19e-05	0.000356	CbGpPWpGaD
Cisapride—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.15e-05	0.000354	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.14e-05	0.000353	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.13e-05	0.000352	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.12e-05	0.000352	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.03e-05	0.000346	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.02e-05	0.000346	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.96e-05	0.000342	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.79e-05	0.000332	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.78e-05	0.000332	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.73e-05	0.000329	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.5e-05	0.000316	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.41e-05	0.000311	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.41e-05	0.000311	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.33e-05	0.000306	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.33e-05	0.000306	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.29e-05	0.000304	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.29e-05	0.000304	CbGpPWpGaD
Cisapride—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.26e-05	0.000302	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.21e-05	0.000299	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.18e-05	0.000298	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.16e-05	0.000297	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.08e-05	0.000292	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.07e-05	0.000291	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.01e-05	0.000288	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.01e-05	0.000288	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.98e-05	0.000286	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.92e-05	0.000283	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.86e-05	0.00028	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.84e-05	0.000278	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.8e-05	0.000276	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.69e-05	0.000269	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.67e-05	0.000268	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.67e-05	0.000268	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.67e-05	0.000268	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.62e-05	0.000266	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.61e-05	0.000265	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.59e-05	0.000264	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.59e-05	0.000264	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.55e-05	0.000261	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.47e-05	0.000257	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.3e-05	0.000247	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.29e-05	0.000247	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.24e-05	0.000244	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.24e-05	0.000244	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.22e-05	0.000243	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.2e-05	0.000241	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.18e-05	0.00024	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.17e-05	0.00024	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.16e-05	0.000239	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.12e-05	0.000237	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.11e-05	0.000236	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.09e-05	0.000235	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.09e-05	0.000235	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.09e-05	0.000235	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.08e-05	0.000235	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.08e-05	0.000235	CbGpPWpGaD
Cisapride—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.06e-05	0.000233	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.04e-05	0.000232	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.02e-05	0.000231	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.02e-05	0.000231	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.9e-05	0.000224	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.79e-05	0.000218	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.78e-05	0.000217	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.77e-05	0.000216	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.73e-05	0.000215	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.72e-05	0.000214	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.71e-05	0.000213	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.7e-05	0.000213	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.69e-05	0.000212	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.67e-05	0.000211	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.67e-05	0.000211	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.65e-05	0.00021	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.63e-05	0.000209	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.62e-05	0.000208	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.62e-05	0.000208	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.61e-05	0.000208	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.61e-05	0.000208	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.57e-05	0.000205	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.56e-05	0.000204	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.55e-05	0.000204	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.54e-05	0.000204	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.52e-05	0.000202	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.51e-05	0.000202	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.49e-05	0.0002	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	3.46e-05	0.000199	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.46e-05	0.000199	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.45e-05	0.000198	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.42e-05	0.000196	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	3.4e-05	0.000195	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.39e-05	0.000195	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.34e-05	0.000192	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.28e-05	0.000189	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.28e-05	0.000188	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.27e-05	0.000188	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.27e-05	0.000188	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.24e-05	0.000186	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.23e-05	0.000185	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.19e-05	0.000183	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.17e-05	0.000182	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.17e-05	0.000182	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.16e-05	0.000182	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.13e-05	0.00018	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.12e-05	0.000179	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.08e-05	0.000177	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.97e-05	0.000171	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.97e-05	0.000171	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.9e-05	0.000166	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.86e-05	0.000164	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.84e-05	0.000163	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.8e-05	0.000161	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.77e-05	0.000159	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.76e-05	0.000159	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.72e-05	0.000156	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.69e-05	0.000154	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.64e-05	0.000152	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.63e-05	0.000151	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.57e-05	0.000148	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.56e-05	0.000147	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.56e-05	0.000147	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.55e-05	0.000147	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.53e-05	0.000145	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.51e-05	0.000144	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.5e-05	0.000144	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.5e-05	0.000144	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	2.5e-05	0.000144	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.5e-05	0.000144	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.48e-05	0.000143	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.46e-05	0.000142	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	2.46e-05	0.000141	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000139	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.4e-05	0.000138	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.37e-05	0.000136	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.34e-05	0.000134	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.33e-05	0.000134	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.31e-05	0.000133	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.28e-05	0.000131	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.23e-05	0.000128	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.2e-05	0.000126	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.19e-05	0.000126	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.18e-05	0.000125	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.17e-05	0.000125	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.16e-05	0.000124	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	2.16e-05	0.000124	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.15e-05	0.000124	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	2.13e-05	0.000122	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.11e-05	0.000121	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	2.09e-05	0.00012	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	2.08e-05	0.000119	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.04e-05	0.000117	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.04e-05	0.000117	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.02e-05	0.000116	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2e-05	0.000115	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	2e-05	0.000115	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.98e-05	0.000114	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.97e-05	0.000113	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.94e-05	0.000112	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.94e-05	0.000111	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.94e-05	0.000111	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.93e-05	0.000111	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.93e-05	0.000111	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	1.92e-05	0.00011	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.91e-05	0.00011	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.91e-05	0.00011	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.91e-05	0.000109	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.9e-05	0.000109	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.9e-05	0.000109	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.88e-05	0.000108	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.78e-05	0.000102	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.78e-05	0.000102	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.77e-05	0.000101	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.76e-05	0.000101	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.76e-05	0.000101	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.75e-05	0.000101	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.75e-05	0.000101	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.75e-05	0.0001	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.73e-05	9.95e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.73e-05	9.94e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.68e-05	9.67e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	9.46e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.62e-05	9.33e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.61e-05	9.25e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.55e-05	8.9e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.54e-05	8.87e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.54e-05	8.83e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.51e-05	8.7e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.5e-05	8.65e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.5e-05	8.65e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1.5e-05	8.63e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.48e-05	8.51e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.47e-05	8.44e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.42e-05	8.16e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.41e-05	8.13e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.41e-05	8.09e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.38e-05	7.91e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.35e-05	7.77e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.34e-05	7.7e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	1.31e-05	7.53e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	1.3e-05	7.48e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.26e-05	7.25e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.25e-05	7.17e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.2e-05	6.91e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.17e-05	6.72e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.16e-05	6.68e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.16e-05	6.67e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.16e-05	6.67e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.15e-05	6.58e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.14e-05	6.56e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.13e-05	6.47e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.08e-05	6.18e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.07e-05	6.14e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.07e-05	6.13e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.06e-05	6.1e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.06e-05	6.09e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.03e-05	5.9e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.29e-06	5.34e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.28e-06	5.33e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.12e-06	5.24e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.05e-06	5.2e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	8.98e-06	5.16e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.84e-06	5.08e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.78e-06	5.04e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	8.23e-06	4.73e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.5e-06	4.31e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.04e-06	4.04e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.99e-06	4.01e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	6.64e-06	3.82e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.62e-06	3.8e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.51e-06	3.74e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	6.49e-06	3.73e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	5.62e-06	3.23e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.02e-06	2.88e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.61e-06	2.65e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	4.58e-06	2.63e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.91e-06	2.25e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.02e-06	1.73e-05	CbGpPWpGaD
